Drugs / cefpirome
cefpirome
also known as
Cefir · Cefpiroma · CEFPIROME SULFATE · Cefpirome sulfate (1:1) · Cefpirome sulphate · Cefrom · HR 810 SULFATE · HR 810 SULPHATE · +1 more
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00280514 | Jan 2006 → Dec 2009 | abscess | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cefpirome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00280514 ↗ |
| Known as | Cefir | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | Cefpiroma | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | CEFPIROME SULFATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | Cefpirome sulfate (1:1) | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | Cefpirome sulphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | Cefrom | “Study drugs: Cefpirome (Cefrom, Aventis): will be administered to patients intravenously as single or multiple doses of 2 g dissolved in 100 mL of distilled water over 20 minutes.” NCT00280514 ↗ |
| Known as | HR 810 SULFATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | HR 810 SULPHATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Known as | HR-810 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL65794 ↗ |
| Modality | Small molecule | — CHEMBL65794 ↗ |
| Route | Intravenous | “will be administered to patients intravenously” NCT00280514 ↗ |